THE OVARIAN ACTION OF INTERLEUKIN-1 IS RECEPTOR-MEDIATED - REVERSAL BY A NATURALLY-OCCURRING INTERLEUKIN-1 RECEPTOR ANTAGONIST

被引:10
|
作者
KOKIA, E [1 ]
BENSHLOMO, I [1 ]
ADASHI, EY [1 ]
机构
[1] UNIV MARYLAND,SCH MED,DEPT OBSTET & GYNECOL,DIV REPROD ENDOCRINOL,BALTIMORE,MD 21201
关键词
INTERLEUKIN-1; INTERLEUKIN-1 RECEPTOR ANTAGONIST; OVARY; GRANULOSA; PROSTAGLANDINS;
D O I
10.1016/S0015-0282(16)57314-2
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To address indirectly the possibility that the ovarian action(s) of interleukin (IL)-1 are receptor mediated and to re-examine the recently reported proposition that the naturally occurring IL-1 receptor antagonist (IL-1ra) may in fact act in the capacity of mixed IL-1 receptor agonist/antagonist. Design: In vitro treatment of isolated granulosa cell (GC) and whole ovarian dispersates of rat origin. Results: Treatment of GC from immature rats with increasing concentrations of IL-1ra (10 to 5,000 ng/mL) proved without effect on either the basal or FSH (100 ng/mL)-supported accumulation of P. Likewise, cellular viability (as assessed by conversion of 3-[4,5-dimethylthiazol-2-yl]-2-5 diphenyltetrazolium bromide to spectrophotometrically detectable formazan) remained unaltered. However, the concomitant addition of increasing concentrations of IL-1ra (10 to 5,000 ng/mL) yielded dose-dependent reversal of the 10 ng/mL IL-1 beta-mediated inhibition of the FSH-supported accumulation of P. Similarly, the ability of IL-1 beta to exert a dose-dependent (0 to 30 ng/mL) antigonadotropic effect was attenuated progressively given the concurrent presence of increasing concentrations (1,000 and 5,000 ng/mL) of IL-1ra. Although treatment of whole ovarian dispersates with 10 ng/mL IL-1 beta resulted in a 5.4-fold increase in the accumulation of prostaglandin (PG)E(2), this effect too was all but eliminated after the concomitant addition of 5 mu g/mL IL-1ra. Conclusions: These observations support the nontoxic nature of IL-1ra, confirm its lack of agonistic activity, validate its utility as an experimental probe, and suggest that neither the basal nor the FSH-stimulated accumulation of P are subject to regulation by endogenously produced GC-derived IL-1-like activity. Moreover, these observations suggest that the ability of IL-1 beta to inhibit the gonadotropin-supported accumulation of P and to increase PGE(2) accumulation is receptor-mediated.
引用
收藏
页码:176 / 181
页数:6
相关论文
共 50 条
  • [21] Mucosal imbalance of interleukin-1β and interleukin-1 receptor antagonist in canine inflammatory bowel disease
    Maeda, Shingo
    Ohno, Koichi
    Nakamura, Kenji
    Uchida, Kazuyuki
    Nakashima, Ko
    Fukushima, Kenjiro
    Tsukamoto, Atsushi
    Goto-Koshino, Yuko
    Fujino, Yasuhito
    Tsujimoto, Hajime
    VETERINARY JOURNAL, 2012, 194 (01) : 66 - 70
  • [22] THE INHIBITORY ACTIVITY OF HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IS ENHANCED BY TYPE-II INTERLEUKIN-1 SOLUBLE RECEPTOR AND HINDERED BY TYPE-I INTERLEUKIN-1 SOLUBLE RECEPTOR
    BURGER, D
    CHICHEPORTICHE, R
    GIRI, JG
    DAYER, JM
    JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) : 38 - 41
  • [23] Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1β synthesis by human neutrophils
    Langereis, J. D.
    Oudijk, E-J. D.
    Schweizer, R. C.
    Lammers, J-W. J.
    Koenderman, L.
    Ulfman, L. H.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (02) : 406 - 415
  • [24] Amyloid formation disrupts the balance between interleukin-1β and interleukin-1 receptor antagonist in human islets
    Hui, Queenie
    Asadi, Ali
    Park, Yoo Jin
    Kieffer, Timothy J.
    Ao, Ziliang
    Warnock, Garth L.
    Marzban, Lucy
    MOLECULAR METABOLISM, 2017, 6 (08): : 833 - 844
  • [25] Human endometrial stromal interleukin-1 beta: Autocrine secretion and inhibition by interleukin-1 receptor antagonist
    Tanaka, T
    Sakamoto, T
    Mizuno, K
    Umesaki, N
    Ogita, S
    HORMONE RESEARCH, 2000, 53 (06) : 300 - 304
  • [26] Deficiency of interleukin-1 receptor antagonist: A systematic review
    Barros, Wergila Ruana Gonsalves
    Gonsalves Junior, Jucier
    ARCHIVES OF RHEUMATOLOGY, 2024, 39 (04) : 566 - 578
  • [27] Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor
    Malinowsky, D
    Lundkvist, J
    Layé, S
    Bartfai, T
    FEBS LETTERS, 1998, 429 (03) : 299 - 302
  • [28] Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites
    Ishihara, Y
    Nishihara, T
    Kuroyanagi, T
    Shirozu, N
    Yamagishi, E
    Ohguchi, M
    Koide, M
    Ueda, N
    Amano, K
    Noguchi, T
    JOURNAL OF PERIODONTAL RESEARCH, 1997, 32 (06) : 524 - 529
  • [29] GROWTH MODULATION OF HUMAN PROSTATIC-CANCER CELLS BY INTERLEUKIN-1 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST
    HSIEH, TC
    CHIAO, JW
    CANCER LETTERS, 1995, 95 (1-2) : 119 - 123
  • [30] Expression of interleukin-1 receptor antagonist in human cornea
    Heur, Martin
    Chaurasia, Shyam S.
    Wilson, Steven E.
    EXPERIMENTAL EYE RESEARCH, 2009, 88 (05) : 992 - 994